4.04
-0.02(-0.49%)
Currency In USD
| Previous Close | 4.06 |
| Open | 4.04 |
| Day High | 4.11 |
| Day Low | 3.97 |
| 52-Week High | 6.71 |
| 52-Week Low | 2.61 |
| Volume | 286,427 |
| Average Volume | 754,515 |
| Market Cap | 512.51M |
| PE | -28.86 |
| EPS | -0.14 |
| Moving Average 50 Days | 4.58 |
| Moving Average 200 Days | 4.14 |
| Change | -0.02 |
If you invested $1000 in Organogenesis Holdings Inc. (ORGO) since IPO date, it would be worth $414.36 as of October 19, 2025 at a share price of $4.04. Whereas If you bought $1000 worth of Organogenesis Holdings Inc. (ORGO) shares 5 years ago, it would be worth $980.58 as of October 19, 2025 at a share price of $4.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
GlobeNewswire Inc.
Oct 01, 2025 8:05 PM GMT
CANTON, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and
Organogenesis Provides Update on Second Phase 3 ReNu® Study
GlobeNewswire Inc.
Sep 25, 2025 8:50 PM GMT
Company maintains confidence in ReNu as innovative pain management therapy Second Phase 3 trial demonstrates numerical improvement in baseline pain reduction over the first Phase 3 trial despite not meeting the primary endpointStatistically significa
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
GlobeNewswire Inc.
Aug 27, 2025 8:05 PM GMT
CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and